|
|||||
|
|
Abciximab provides cost-effective survival advantage in high-volume interventional practice |
|
| Authors: | Kereiakes D J Obenchain R L Barber B L Smith A McDonald M Broderick T M Runyon J P Shimshak T M Schneider J F Hattemer C R Roth E M Whang D D Cocks D Abbottsmith C W |
| Affiliation: | Carl and Edyth Lindner Center for Research and Education, Cincinnati, Ohio, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |